Research

Cardiogen: Research Overview

Cardiogen (Ala-Glu-Asp-Arg, also referenced by CAS number 857267-11-9) is a synthetic tetrapeptide bioregulator studied in relation to cardiomyocyte proliferation and apoptosis in cardiac tissue culture models.

An animal study using organotypic myocardial tissue cultures from young (3-month-old) and aged (24-month-old) rats examined the effects of 20 individual amino acids and the synthetic tetrapeptide cardiogen, each at a concentration of 10⁻¹² M, on cell proliferation and apoptosis. Cardiogen strongly stimulated proliferation in tissue from both age groups, outperforming the amino acids tested individually, and immunohistochemistry showed a reduction in p53 protein expression, suggesting inhibition of apoptosis in the myocardial tissue (PubMed).

For laboratory research use only — not for human consumption. This content is presented for educational and informational purposes and is not intended as medical advice, a treatment claim, or usage instruction.

View Cardiogen (20mg)

Related Research

2 thoughts on “Cardiogen: Research Overview

Leave a Reply